GlaxoSmithKline
GSK
#232
Rank
NZ$138.20 B
Marketcap
$67.97
Share price
1.03%
Change (1 day)
-5.26%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.67

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $6.11. In 2022 the company made an earnings per share (EPS) of $14.81 an increase over its 2021 EPS that were of $5.23.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.67-61.7%
2022$14.81183.39%
2021$5.23-17.83%
2020$6.3621.82%
2019$5.2223.91%
2018$4.21141.48%
2017$1.7564.6%
2016$1.06-90.64%
2015$11.33178.14%
2014$4.07-48.16%
2013$7.8522.63%
2012$6.41-11.32%
2011$7.22230.25%
2010$2.19-70.98%
2009$7.546.76%
2008$7.06-15.14%
2007$8.327.82%
2006$7.7219.61%
2005$6.4518.56%
2004$5.440.36%
2003$5.4250.39%
2002$3.6131.13%
2001$2.75-25.43%
2000$3.6931.58%
1999$2.801.05%
1998$2.77-0.98%
1997$2.80-10.07%
1996$3.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.47-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.25-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.53 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.55-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.49-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.52-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA